Unknown

Dataset Information

Pharmacological characterisation of novel adenosine A3 receptor antagonists.


ABSTRACT: The adenosine A3 receptor (A3R) belongs to a family of four adenosine receptor (AR) subtypes which all play distinct roles throughout the body. A3R antagonists have been described as potential treatments for numerous diseases including asthma. Given the similarity between (adenosine receptors) orthosteric binding sites, obtaining highly selective antagonists is a challenging but critical task. Here we screen 39 potential A3R, antagonists using agonist-induced inhibition of cAMP. Positive hits were assessed for AR subtype selectivity through cAMP accumulation assays. The antagonist affinity was determined using Schild analysis (pA2 values) and fluorescent ligand binding. Structure-activity relationship investigations revealed that loss

SUBMITTER: Barkan K 

PROVIDER: S-EPMC7695835 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature